YQ-138

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameYQ-138
Drug Alias NameYQ-138
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCerebrovascular Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A